drugset / Trial / NCT05138770

Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects

NCT05138770 ↗

Phase 1 Completed 78 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedSequentialDouble-blindTreatment

Summary

This clinical trial consists of two parts:1. a randomized, double-blind, single-center, placebo-controlled, dose-escalation PK study; 2. food effects and drug metabolism transformation study. The main purpose of this trial is to evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics and Food effects of VC005 Tablets in healthy subjects.

Timeline

Start
2021-11-18
Primary completion
2022-08-26
Completion
2022-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown 1 mg —
Subject VC005 Unknown 5 mg —
Subject VC005 Unknown 10 mg —
Subject VC005 Unknown 25 mg —
Subject VC005 Unknown 50 mg —
Subject VC005 Unknown 100 mg —